Connecting the Upper Middle Neighborhoods of Phoenix - Arcadia, Biltmore, North Central
No Result
View All Result
SUBSCRIBE
The Upper Middle
  • All News
    • Business
    • Commentary
    • Community
    • Culture
    • Education
    • Events
    • Family
    • Food & Drink
    • Lifestyle & Fitness
    • Local News
    • Real Estate
  • Business Directory
The Upper Middle
  • All News
    • Business
    • Commentary
    • Community
    • Culture
    • Education
    • Events
    • Family
    • Food & Drink
    • Lifestyle & Fitness
    • Local News
    • Real Estate
  • Business Directory
No Result
View All Result
SUBSCRIBE
The Upper Middle
No Result
View All Result

FDA Press Release Claims Heartburn Medicine May Have Low Levels of Cancer-Causing Contaminant

  • September 16, 2019
  • theumphx
  • The Upper Middle

In a press release Friday, the FDA claims that low levels on cancer-causing contaminants have been found in heartburn medication, specifically Zantac.

Low levels of N-nitrosodimethylamine, or NDMA were found in the medicine called Ranitidine, which is used to treat acid reflux and heartburn. Zantac is the name brand of Ranitidine.

The FDA encourages people who are already taking Zantac continue to do so while an investigation is taking place. Anyone who wants to stop taking Zantac should talk to their doctor before they do so.

“Although NDMA may cause harm in large amounts, the levels the FDA is finding in ranitidine from preliminary tests barely exceed amounts you might expect to find in common foods,” the agency said.

The FDA is “evaluating the risk to patients” and will provide their findings as soon as they are able to.

Back in July of 2018, NDMA was found in some blood pressure medications, which spurred a recall.

“Patients should be able to trust that their medicines are as safe as they can be and that the benefits of taking them outweigh any risk to their health,” Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said in a statement.

Health officials in Europe have announced that now they too are investigating NDMA contamination in ranitidine.

Click here to read the FDA’s press release.

Sponsored Ad

RECENT NEWS

Uncrustables® Launches First-Ever Limited-Edition Flavor: Peanut Butter & Mixed Berry Spread Sandwiches Debut Nationwide This Summer

Waymo’s Expansion Brings More Driverless Cars to Phoenix Neighborhoods Like Arcadia and North Central

Phoenix–Paris Takes Off: Air France Expands Sky Harbor Service to Five Weekly Flights

Snoop Dogg’s Doggyland Joins KIDZ BOP Live Tour, Coming to Phoenix August 29

Teacher Appreciation Week 2025: 10 Unique Gift Ideas to Thank Teachers in a Meaningful Way

The Stories Behind Taylor Swift’s Top 40 Songs: Love, Growth, and Everything In Between

Next Post
Badge Bash 2019 Gives Attendees The Chance To Experience Girl Scouting For A Night

Badge Bash 2019 Gives Attendees The Chance To Experience Girl Scouting For A Night

Fose + McKay Fose + McKay Fose + McKay
The Upper Middle Phoenix
The Upper Middle Phoenix (The UM) is your go-to source for local news, events, business updates, and culture in Arcadia, North Central Phoenix, and Biltmore. We also cover Paradise Valley and Downtown Phoenix, bringing you the latest on food & drink, real estate, outdoor activities, and community happenings.
Connecting the Upper Middle Neighborhoods of Phoenix - Arcadia, Biltmore, North Central

Subscribe To Our Newsletter

SUBSCRIBE

©2025 The Upper Middle 1801 East Camelback Road, Suite 201, Phoenix, AZ 85016 / 602.222.4700 / [email protected] 

Max Fose – Publisher | Privacy Policy | Advertise With Us | Media Kit | About The Upper Middle Phoenix

No Result
View All Result
  • Home
  • All News
    • Business
    • Commentary
    • Community
    • Culture
    • Education
    • Events
    • Family
    • Food & Drink
    • Lifestyle & Fitness
    • Local News
    • Real Estate
  • Business Directory
Connecting the Upper Middle Neighborhoods of Phoenix - Arcadia, Biltmore, North Central

©2025 The Upper Middle 1801 East Camelback Road, Suite 201, Phoenix, AZ 85016 / 602.222.4700 / [email protected]